97 related articles for article (PubMed ID: 1401833)
21. Diagnostic usefulness of serum group I pepsinogen determination.
Peyre S; Di Napoli A; Pelissero A; Sategna-Guidetti C
Gastroenterol Clin Biol; 1983 Oct; 7(10):793-8. PubMed ID: 6628912
[TBL] [Abstract][Full Text] [Related]
22. [Correlation of serum pepsinogen level and gastric mucosal changes of residents in the high incidence area of gastric cancer].
Zhang XH; Huang B; Wang JL; Li YH; Mi JM; Shen HT; Zhang ZG; Yan X; Xing LX; Wang SJ
Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):507-11. PubMed ID: 17147114
[TBL] [Abstract][Full Text] [Related]
23. [Zymogenic cell mass and serum pepsinogen I: the cell secretory correlations in patients with gastric intestinal-type cancer of the corpus-fundus].
Testino G; Perasso A
Minerva Med; 1992 Sep; 83(9):507-11. PubMed ID: 1436599
[TBL] [Abstract][Full Text] [Related]
24. Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia.
Samloff IM; Varis K; Ihamaki T; Siurala M; Rotter JI
Gastroenterology; 1982 Jul; 83(1 Pt 2):204-9. PubMed ID: 7084603
[No Abstract] [Full Text] [Related]
25. [Mass screening of stomach neoplasms by serum pepsinogen analysis].
Miki K
Nihon Naika Gakkai Zasshi; 1992 May; 81(5):654-9. PubMed ID: 1512496
[No Abstract] [Full Text] [Related]
26. Clinical significance of pepsinogen A isozymogens, serum pepsinogen A and C levels, and serum gastrin levels.
Westerveld BD; Pals G; Lamers CB; Defize J; Pronk JC; Frants RR; Ooms EC; Kreuning J; Kostense PJ; Eriksson AW
Cancer; 1987 Mar; 59(5):952-8. PubMed ID: 3815274
[TBL] [Abstract][Full Text] [Related]
27. Clinical implications of serum pepsinogen and progastricsin in man.
Axelsson CK
Scand J Clin Lab Invest Suppl; 1992; 210():81-96. PubMed ID: 1455183
[TBL] [Abstract][Full Text] [Related]
28. Serum pepsinogens I and II and gastric mucosal histology after partial gastrectomy.
Sipponen P; Samloff IM; Saukkonen M; Varis K
Gut; 1985 Nov; 26(11):1179-82. PubMed ID: 4065694
[TBL] [Abstract][Full Text] [Related]
29. Helicobacter pylori antibodies in relation to precancerous gastric lesions in a high-risk Chinese population.
Zhang L; Blot WJ; You WC; Chang YS; Kneller RW; Jin ML; Li JY; Zhao L; Liu WD; Zhang JS; Ma JL; Samloff IM; Correa P; Blaser MJ; Xu GW; Fraumeni JF
Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):627-30. PubMed ID: 8824365
[TBL] [Abstract][Full Text] [Related]
30. O6-methylguanine in blood leucocyte DNA: an association with the geographic prevalence of gastric cancer and with low levels of serum pepsinogen A, a marker of severe chronic atrophic gastritis. The EUROGAST Study Group.
Carcinogenesis; 1994 Sep; 15(9):1815-20. PubMed ID: 7923573
[TBL] [Abstract][Full Text] [Related]
31. [The effect of food intake on the content of proteolytic enzymes and gastrin in the blood of patients with peptic ulcer and chronic atrophic gastritis].
Eremina EIu
Vopr Pitan; 1991; (4):19-21. PubMed ID: 1792741
[TBL] [Abstract][Full Text] [Related]
32. Correlation between the prevalence of gastritis and gastric cancer in Japan.
Fukao A; Hisamichi S; Ohsato N; Fujino N; Endo N; Iha M
Cancer Causes Control; 1993 Jan; 4(1):17-20. PubMed ID: 8431526
[TBL] [Abstract][Full Text] [Related]
33. [Comparative study between seric I pepsinogen and seric gastrin, in the differentiation of the different types and localizations of chronic gastritis].
Sánchez Rodríguez A; Martín Oterino JA; Chimpen Ruiz V; Alonso Hernández P; Araoz Sánchez P; Portugal Alvarez J
An Med Interna; 1996 Dec; 13(12):576-9. PubMed ID: 9063931
[TBL] [Abstract][Full Text] [Related]
34. Validity of serum pepsinogen levels and quininium resin test combined for gastric cancer screening.
Kim JR; Lee K; Jung WT; Lee OJ; Kim TH; Kim HJ; Lee JS; Passaro DJ
Cancer Detect Prev; 2005; 29(6):570-5. PubMed ID: 16289505
[TBL] [Abstract][Full Text] [Related]
35. Serum pepsinogen I and the state of gastric mucosa in an Estonian population sample.
Tamm A; Villako K; Härkönen M; Karonen SL
Scand J Gastroenterol; 1984 Nov; 19(8):1091-4. PubMed ID: 6549483
[TBL] [Abstract][Full Text] [Related]
36. The Serum Pepsinogen Test as a Predictor of Kazakh Gastric Cancer.
Juan Cai W; Yin L; Kang Q; Chen Zeng Z; Liang Wang S; Cheng J
Sci Rep; 2017 Mar; 7():43536. PubMed ID: 28251999
[TBL] [Abstract][Full Text] [Related]
37. Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients.
Ohkusa T; Miwa H; Nomura T; Asaoka D; Kurosawa A; Sakamoto N; Abe S; Hojo M; Terai T; Ogihara T; Sato N
Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():25-32. PubMed ID: 15298602
[TBL] [Abstract][Full Text] [Related]
38. Helicobacter pylori, pepsinogen, and risk for gastric adenocarcinoma.
Parsonnet J; Samloff IM; Nelson LM; Orentreich N; Vogelman JH; Friedman GD
Cancer Epidemiol Biomarkers Prev; 1993; 2(5):461-6. PubMed ID: 8220091
[TBL] [Abstract][Full Text] [Related]
39. Screening markers for chronic atrophic gastritis in Chiapas, Mexico.
Ley C; Mohar A; Guarner J; Herrera-Goepfert R; Figueroa LS; Halperin D; Parsonnet J
Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):107-12. PubMed ID: 11219766
[TBL] [Abstract][Full Text] [Related]
40. Relationship between Helicobacter pylori status and serum pepsinogens as serologic markers in atrophic gastritis.
Bölükbaş C; Bölükbaş FF; Ovünç O; Kiliç G; Dalay R; Güven H; Uras F; Yardimci TK; Sökmen MH; Agan AF; Pişkinpaşa N
Turk J Gastroenterol; 2006 Sep; 17(3):172-6. PubMed ID: 16941249
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
